Teicneolaíocht Éifeachtach Sintéise Peptide Bunaithe ar Staidéir Táirgthe Ceimic Chomhfhiúsacha Dinimiciúla

Teicneolaíocht Éifeachtach Sintéise Peptide Bunaithe ar Staidéir Táirgthe Ceimic Chomhfhiúsacha Dinimiciúla

Background and Challenges

Since the first peptide gly-gly was synthesized in 1901, peptide synthesis has undergone more than 100 years of development, and as an important participant in life activities, it has shown great potential in the fields of drug discovery and development, biomaterials, and cosmetics. Traditional peptide synthesis methods are inefficient, costly, and environmentally polluting, which seriously restrict their wide application. The development of efficient, green and economical peptide synthesis technology has become an urgent challenge. Anseo, based on the theoretical foundation of scientific research, we apply the theory to practice and successfully realize the application of catalytic peptide synthesis technology in actual production.


Technological breakthrough

Bifunctional organic small molecule catalyst: Using thiourea-tertiary amine synergistic catalysis, we successfully avoided the involvement of metal and realized the green coupling technology without metal.

  • Unique reaction mechanism: tertiary amine pulls hydrogen to improve the nucleophilicity of amino group, and thiourea’s rigid structure realizes the function of capturing the amino group, thus realizing the fixed-point catalysis.
  • Significantly improved coupling efficiency: the coupling efficiency of a single step under liquid phase conditions has been shortened to 5 minutes, and the coupling efficiency is as high as 99%.
  • Green chemistry technology: water/ionic liquid system replaces DMF to reduce organic waste emission, and the by-product is only water, simple post-processing, and suitable for continuous flow reactor, realizing continuous peptide synthesis on the scale of kilograms.

Conclusion

The thiourea-tertiary amine co-catalyzed peptide synthesis technology can rapidly construct peptide libraries for high-throughput screening, significantly shorten the R&D cycle of anticancer and antiviral drugs, support the large-scale production of complex peptides, and promote more peptide drugs to enter into the clinical research. It reduces the use of reagents and solvents, and successfully lowers the cost of peptide synthesis, and can rapidly realize the large-scale synthesis of peptides.

Avatar admin

Zejun Peng

Príomhoifigeach Teicneolaíochta; Saineolaí Sintéise Peptide Saineolas Croí: Sintéis peptide Coimpléasc, modhnuithe aimínaigéad neamhnádúrtha, agus tógáil peiptídí timthriallacha agus peiptídí stáplacha.

Beathaisnéis:Tá taithí fhairsing ag Zejun Peng ar cheimic orgánach agus sintéis peiptíde. Tá sé inniúil i bhfeidhmiú comhcheangailte sintéis peptide soladach-chéim (SPSS) agus sintéis peptide leachtach-chéim (LPPS), agus tá an-oilte aige ar sheichimh thar a bheith deacair a shintéisiú a shárú (cosúil le peptides ultra-slabhra fada, seichimh an-hidreafóbach, agus fillte bannaí disulfide iolrach). Faoina cheannaireacht, d'éirigh leis an bhfoireann baic theicniúla a shárú i roinnt modhnuithe speisialaithe (mar N-meitilation, PEGylation, agus lipéadú fluaraiseacha), ráta ratha sintéise de bhreis a choinneáil 98%.

Seiceáilte Fíricí & Treoirlínte Eagarthóireachta
Athbhreithnithe ag: Saineolaithe Ábhar
Roinn an t-alt seo
Baile Cuardach Whatsapp Seirbhísí Táirge